4D Molecular Therapeutics, Inc.
FDMT
$6.58
$0.436.99%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -78.49% | -68.75% | -59.53% | -49.56% | 1.32% |
| Total Depreciation and Amortization | 16.35% | 15.75% | 16.63% | 14.40% | 19.97% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.11% | -3.08% | 2.01% | 8.13% | 8.75% |
| Change in Net Operating Assets | 809.19% | -294.50% | -14.76% | 1,354.85% | 90.02% |
| Cash from Operations | -95.40% | -99.10% | -77.57% | -54.55% | 8.64% |
| Capital Expenditure | -70.09% | -50.14% | -36.63% | -2.14% | 58.70% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 117.94% | 98.13% | -352.05% | -447.80% | -505.14% |
| Cash from Investing | 116.73% | 96.21% | -361.36% | -465.02% | -535.35% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -99.42% | -96.04% | 115.04% | 120.86% | 142.53% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 183.36% |
| Cash from Financing | -99.42% | -96.04% | 115.04% | 121.53% | 144.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -136.83% | -172.11% | -150.71% | -152.66% | -138.47% |